CHCarwyn Rhys Hooper

Carwyn Rhys Hooper

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carwyn Rhys Hooper has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Current appeal system for those detained in England and Wales under the Mental Health Act needs reform

    by Paul Gosney, Paul Lomax, Carwyn Hooper, Aileen O’brien

    The approach to managing the involuntary detention of people suffering from psychiatric conditions can be divided into those with clinicians at the forefront of decision-making and those who rely heavily on the judiciary. The system in England and Wales takes a clinical approach where doctors have widespread powers to detain and treat patients involuntarily. A protection in this system is the right of the individual to challenge a decision to deprive them of their liberty or treat them against their will. This protection is provided by the First-tier Tribunal; however, the number of successful appeals is low. In this paper, the system of appeal in England and Wales is outlined. This is followed by a discussion of why so few patients successfully appeal their detention with the conclusion that the current system is flawed. A number of recommendations about how the system might be reformed are offered.


  • Institute of Medical Ethics Guidelines for confirmation of appointment, promotion and recognition of UK bioethics and medical ethics researchers

    by Lucy Frith, Carwyn Hooper, Silvia Camporesi, Thomas Douglas, Anna Smajdor, Emma Nottingham, Zoe Fritz, Merryn Ekberg, Richard Huxtable

    This document is designed to give guidance on assessing researchers in bioethics/medical ethics. It is intended to assist members of selection, confirmation and promotion committees, who are required to assess those conducting bioethics research when they are not from a similar disciplinary background. It does not attempt to give guidance on the quality of bioethics research, as this is a matter for peer assessment. Rather it aims to give an indication of the type, scope and amount of research that is the expected in this field. It does not cover the assessment of other activities such as teaching, policy work, clinical ethics consultation and so on, but these will be mentioned for additional context. Although it mentions the UK’s Research Excellence Framework (REF), it is not intended to be a detailed analysis of the place of bioethics in the REF.

  • The ethics of setting national antibiotic policies using financial incentives

    by Grace Li, Carwyn Hooper, Andrew Papanikitas, Susan Hopkins, Mike Sharland

    The Department of Health’s 5-year strategy to reduce morbidity and mortality associated with AMR (2013–2018) focused on optimising antibiotic prescribing and improving infection prevention and control.1 In April 2015 NHS England introduced a Quality Premium (QP) focusing on reducing antibiotics. QPs are financial rewards, with a maximal value equivalent to £5 per patient, intended to reward clinical commissioning groups (CCGs) for improvements in the quality of the services that they commission and for associated improvements in health outcomes and reducing inequalities. The AMR QP provided commissioners with financial incentives to reduce antibiotic prescribing; 80% were linked to primary care quality measures (reduction in absolute number of antibiotic prescriptions by 1%, decrease in use of broad spectrum antibiotics by 10%) and 20% linked to improving availability of antibiotic prescribing data from secondary care.2


  • Open Access

    Should psychiatrists ‘Google’ their patients?

    by G. Alice Ashby, Aileen O'BRien, Deborah Bowman, Carwyn Hooper, Toby Stevens, Esther Lousada

    Summary: Since its beginnings in the 1980s the internet has come to shape our everyday lives, but doctors still seem rather afraid of it. This anxiety may be explained by the fact that researchers and regulatory bodies focus less on the way that the internet can be used to enhance clinical work and more on the potential and perceived risks that this technology poses in terms of boundary violations and accidental breaches of confidentiality. Some aspects of the internet's impact on medicine have been better researched than others, for example, whether email communication, social media and teleconferencing psychotherapy could be used to improve the delivery of care. However, few authors have considered the specific issue of searching online for information about patients and much of the guidance published by regulatory organisations eludes this issue. In this article we provide clinical examples where the question ‘should I Google the patient?’ may arise and present questions for future research.


  • Skidding at Speed

    by John Ma Spicer, Carwyn R. PhD Hooper

  • Ethical implications of HIV self-testing

    by Jonathan Youngs, Carwyn Hooper

    In April 2015, the first legally approved HIV self-testing kit went on sale in the UK—except Northern Ireland where they remain illegal. These tests allow individuals to test their HIV status and read the result in the privacy of their own home, much like a home pregnancy test. This paper explores the ethical implications of HIV self-testing. We conclude that there are no strong ethical objections to self-testing being made widely available in the UK. Pretest counselling for an HIV test is not an ethical necessity, and self-testing has the potential to increase early diagnosis of HIV infection and thus improve prognosis and reduce ongoing transmission. Self-testing kits might also empower people and promote autonomy by allowing people to dictate the terms on which they test their HIV status. We accept that there are some potential areas of concern. These include the possibility of user error with the tests, and the concern that individuals may not present to health services following a reactive result. False negatives have the potential to cause harm if the ‘window period’ is not understood, and false positives might produce psychological distress. There is, however, little evidence to suggest that self-testing kits will cause widespread harm, and we argue that the only way to properly evaluate whether they do cause significant harm is to carefully evaluate their use, now that they are available on the market.


  • Placebos and sham treatments

    by Philip Sedgwick, Carwyn Hooper

    The effectiveness of topical chloramphenicol in preventing wound infection after minor dermatological surgery was evaluated. A randomised placebo controlled superiority trial was performed.1 Participants were patients with high risk sutured wounds who had undergone minor surgery. The intervention was a single application of topical chloramphenicol ointment to the sutured wound immediately after suturing. Chloramphenicol ointment is an antibiotic indicated for the treatment of bacterial conjunctivitis, but it is often used as prophylaxis for, or treatment of, wound infection, although little evidence exists for its effectiveness. The control treatment was placebo ointment, which consisted of a mixture of soft white and liquid paraffin with no known anti-infective properties. In total, 972 patients were recruited and randomised to topical chloramphenicol ointment (n=488) or placebo (n=484). All participants were instructed to follow standard management, keeping their wound dry and covered for 24 hours after surgery. The primary outcome was infection on the agreed day of removal of sutures or sooner if the patient re-presented with a perceived infection. The percentage of participants with an infection in the topical chloramphenicol group was significantly lower than in the placebo group (6.6% v 11.0%; difference −4.4%, 95% confidence interval −7.9% to −0.8%; P=0.010). Although the application of a single dose of topical chloramphenicol to high risk sutured wounds after minor surgery produced a statistically significant reduction in the infection rate, the researchers concluded that the reduction …


  • Military medical ethics: a call to regulatory and educational arms

    by Carwyn Rhys Hooper, Jim Ryan, Elizabeth Pelham, Steve Mannion


  • Ethics virtual patients: a new pedagogical tool for educators?

    by Carwyn Hooper

    Virtual patient (VP) cases are interactive computer simulations of real life scenarios that have been used in medical education for over a decade. They are popular with students and staff alike and have been shown to improve knowledge retention, clinical reasoning and decision-making skills. Ethics virtual patient (EVP) cases are interactive computer simulations of real life scenarios which have a substantive ethical component. They can also contain significant legal and professionalism components. EVP cases have only recently been used in medical education, but there is growing evidence to suggest that medical students find them interesting, engaging and helpful. This paper will provide a brief overview of the way in which EVP cases have been used at St George's, University of London and explore the pedagogical rationale for using these cases to teach ethics, law and professionalism to medical students.